Atrium Health University City is a 130-bed acute care facility located in Charlotte's University City area. This hospital is the location of the second busiest emergency departments in Mecklenburg County. It is owned by Atrium Health, one of the nation's largest publicly owned, not-for-profit hospital operators.

There are 130 beds in Atrium Health University City/LCI-University.

During the past decade, Atrium Health University City/LCI-University conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 3 clinical trials were completed, i.e. on average, 11.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atrium Health University City/LCI-University" #1 sponsor was "National Cancer Institute (NCI)" with 9 trials, followed by "NRG Oncology" with 6 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored, "Wake Forest University Health Sciences" with 3 trials sponsored and "Alliance for Clinical Trials in Oncology" with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atrium Health University City/LCI-University" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Donaghue Medical Research Foundation" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Atrium Health University City/LCI-University" are "Colon Adenocarcinoma" (3 trials), "Invasive Breast Carcinoma" (2 trials), "Rectal Adenocarcinoma" (2 trials), "Stage III Rectal Cancer AJCC v7" (2 trials) and "Stage IIIA Breast Cancer" (2 trials). Many other conditions were trialed in "Atrium Health University City/LCI-University" in a lesser frequency.

Most popular intervention types in "Atrium Health University City/LCI-University" are "Drug" (20 trials), "Other" (15 trials), "Radiation" (12 trials), "Procedure" (10 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (8 trials), "Biospecimen Collection" (6 trials), "Computed Tomography" (5 trials), "Magnetic Resonance Imaging" (5 trials) and "Radiation Therapy" (5 trials). Other intervention names were less common.

The vast majority of trials in "Atrium Health University City/LCI-University" are 24 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Atrium Health University City/LCI-University". undefined are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Atrium Health University City/LCI-University, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Atrium Health University City/LCI-University, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".